Find Quick Relief from Depression - Explore SPRAVATO
Treatment Near You
SPRAVATO® is the only FDA-approved nasal spray for adults with treatment-resistant depression, providing relief when two or more oral antidepressants have not been effective. It can be taken with or without an oral antidepressant to help reduce depression symptoms. Find renewed hope and vitality, often experiencing significant improvement in their symptoms within hours or days of treatment.
Feel Better, Faster with Expert Psychiatric Services
Online Psychiatric Consultations
Choose how you prefer to connect with your psychiatrist. Book an online consultation at your convenience.
Personalized Medication
Management
Your psychiatrist will be a partner in your treatment process, developing a medication regimen that works best for you.
On-going
Care
Get rapid access to mental health support and connect with a licensed providers instantly. Our team ensures immediate assistance to severe cases.
What is SPRAVATO®?
SPRAVATO® is a ketamine-based and FDA-approved medication that is used to treat Major Depressive Disorder (MDD) and Treatment Resistant Depression (TRD). It comes as a nasal spray self-administered under observation at specialty treatment centers. Ketamine often acts more quickly than many traditional antidepressants, and some patients may notice a reduction in depressive symptoms within about 24 hours of the first dose. Individual responses vary.
Is SPRAVATO® right for me?
If you have already tried two or more antidepressants but are still suffering from symptoms of depression disorder, there is a good chance that you have Treatment
Resistant Depression (TRD). You can discuss with your healthcare provider if you
are a good candidate for SPRAVATO®.
Clinical studies suggest SPRAVATO® can be effective for some adults with treatment-resistant depression when used with an oral antidepressant. While SPRAVATO® is preferred for rapid relief, its effectiveness varies from patient to patient. The long-term efficacy of SPRAVATO® is still under investigation, but early evidence suggests that its positive effects can endure with ongoing use.
How is SPRAVATO® administered?
SPRAVATO® is only available at certified treatment centers and cannot be taken home. It is self-administered at specialty centers under the observation of healthcare professionals. Although SPRAVATO® is similar to a nasal congestion spray, its disassociation and sedation side effects make it difficult to administer at home. A quick search of Spravato treatment near me can help you in finding the right treatment near you.
After receiving a dose, patients are monitored for two hours to ensure they do not have any serious side effects. Patients are not advised to handle any heavy machinery or drive the day they get their dose.
The Science Behind SPRAVATO®: SPRAVATO® vs. Ketamine
SPRAVATO® is a esketamine nasal spray treatment. Ketamine is a combination of 2 molecules, S-ketamine (esketamine) and R-ketamine (arketamine). Spravato is the S-ketamine part of ketamine (hence the name “esketamine”). There is significant data that indicates that esketamine may be more potent than arketamine, but dosing, route of administration, and the setting in which the medication is administered, along with other variables, all affect the experience you have while being treated.
How Does it Work?
Start your Intake Process
After requesting an appointment, one of our Intake Specialists will be contacting you shortly to begin the intake process. Choose a date and time that suits you.
Provide your Details
Fill in your details to book the appointment. You will meet with a doctor after your intake process has been completed.
Voila! Your Appointment is Scheduled
Congratulations on completing the first step towards your mental wellness. You will get a confirmation in your provided email with all the details of your first appointment.
Is a Psychiatrist the Right Choice for Your Mental Health?
If you’re struggling with severe mental health
issues, considering psychiatry might be a beneficial step. Let’s explore why:
Psychiatrists
Medication-Based Psychiatric Services
SPRAVATO®: It is a ketamine-based and FDA-approved nasal spray prescription medication that is used to treat treatment-resistant depression (TRD) in adult patients. It works by targeting specific receptors in the brain and helps regulate mood.
SUBOXONE: Buprenorphine/Naloxone is a combination medication that is used to treat opioid addiction. Buprenorphine aids in reducing the withdrawal symptoms and cravings, while naloxone prevents chances of an overdose.
Testimonials
I was so surprised by how simple and convenient it was to set up my first online appointment. The virtual appointments fit perfectly into my busy schedule, and I didn’t even have to leave my house. It’s such a relief knowing help is just a few clicks away!
The medications prescribed by my psychiatrist have been life-changing. They listened to my concerns, explained the options, and found the right balance for me. I finally feel like myself again after years of struggling!
What I love most is having a key role in creating my treatment process. A psychiatrist who considers my preferences and adapts based on my response makes all the difference. It's great to be an active part of my own care.
The care team was truly amazing! They are so quick in response to my questions and always make me feel heard and understood. It's so nice to feel that I have such a supportive team that looks after my mental health.
Emergency Numbers and Clinic Locations
988
Call or text the National Suicide Prevention Lifeline for 24/7 emotional support.
911
If you’re having a medical or mental health emergency, call 911 or go to your local ER.
Get Directions
Get Directions
Get Directions
Get Directions
Get Directions
Get Directions
Get Directions
Get Directions
Get Directions
Get Directions
SPRAVATO® Insights and Resources
Depression is tiring and emotionally exhausting for those who have tried standard methods of Spravato
Finding hope for individuals living with depression that has not responded to conventional meds can
For people who have been through a variety of antidepressants without much success, finding Spravato
FAQs
Yes, SPRAVATO® contains esketamine, a controlled substance in the United States. Esketamine is an s-enantiomer of ketamine. These substances are listed under Schedule III of the Controlled Substances Act (CSA).
Therapeutic effects of SPRAVATO® usually become visible after a couple of weeks of continuous treatment. Typically, a treatment plan is designed to include two weekly sessions during the first month. This routine is followed by one weekly session for the next four weeks.
SPRAVATO® may cause sleepiness in some patients while sedation in others. Some patients may experience fainting, dizziness, or anxiety. If you experience any such symptoms, tell your healthcare providers immediately
The peak effect of SPRAVATO® is during the first 2 hours of intake. After 2-4 hours, its effect starts declining in your body. Sometimes, it might take 6-12 hours to leave your system.
Mainly, you should avoid alcohol and CNS depressant medications, including opioids, benzodiazepines, and some anti-depressants. These medications, together with SPRAVATO®, adversely interact with the CNS system. If you take SPRAVATO® together with CNS depressants, this could increase the chances of dizziness and drowsiness.
